Clinical Trials Browser

Phase 3 × Lung Diseases × alectinib × Clear all

NCT06765109 2026-02-17

ALKAZAR

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms